Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

VUITY 1.25% EYE DROP

Pilocarpine Hydrochloride
$23.5529per ML
High Outlier

Strength

12.5 mg/mL

Manufacturer

AbbVie Inc.

NDC

00074709806

Classification

Brand

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Last Updated

1/2/2026

Active Ingredients

PILOCARPINE HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA214028

On Market Since

10/28/2021

Pharmacological Classes

Cholinergic Agonists
Cholinergic Muscarinic Agonists
Cholinergic Receptor Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+4.9%

1Y

+4.4%

3Y

N/A

5Y

N/A

All

+4.0%

Generic Alternatives

2 alternatives • Same active ingredient

PILOCARPINE HCL 1.25% EYE DROP
Generic
60219236602•Amneal Pharmaceuticals NY LLC
$24.1035
+2% more
VUITY 1.25% EYE DROP
Brand
00074709804•AbbVie Inc.
$31.0595
+32% more

Related Drugs

Same classification

EVOXAC 30 MG CAPSULE
Brand
00713088301•Cosette Pharmaceuticals, Inc.
$7.8316
per EA
CHANTIX 0.5 MG TABLET
Brand
00069046856•Pfizer Inc.
$7.8518
per EA
CHANTIX 1 MG TABLET
Brand
00069046956•Pfizer Inc.
$8.0100
per EA
COBENFY 100 MG-20 MG CAPSULE
Brand
00003110060•E.R. Squibb & Sons, L.L.C.
$30.3016
per EA
COBENFY 50 MG-20 MG CAPSULE
Brand
00003005060•E.R. Squibb & Sons, L.L.C.
$30.3045
per EA
COBENFY 125 MG-30 MG CAPSULE
Brand
00003012560•E.R. Squibb & Sons, L.L.C.
$30.3223
per EA
TYRVAYA 0.03 MG NASAL SPRAY
Brand
73521003002•Oyster Point Pharma, Inc.
$79.5629
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy